🚀New NLCA publication: Utilisation patterns of systemic anticancer therapy (SACT) in patients with advanced non-small cell lung cancer (NSCLC) in England Read here👉 bmjoncology.bmj.com/content/5/1/... @hqip.bsky.social @btog.bsky.social @lcnuk.bsky.social

"Fantastic conference with very insightful talks and sessions!" Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

BTOG informs members of NICE's new recommendation: serplulimab with carboplatin and etoposide for untreated extensive-stage small cell lung cancer. Details: https://www.nice.org.uk/guidance/indevelopment/gid-ta11405/documents

“The UK is genuinely world-leading in lung cancer data” Are you using your data? Listen now 🎧 https://www.btog.org/btog-nlca-webinar-state-of-the-nation-2026/ National Lung Cancer Audit

We’re always looking to improve. Tell us what matters to you in the BTOG Membership Survey 2026. 👉 https://www.btog.org/btog-membership-survey-2026/

BTOG wishes to inform members of a new NICE release that has been published today. NICE has recommended cemiplimab with platinum-based chemotherapy - it can be used as an option for untreated non-small-cell lung cancer (NSCLC) in adults - details www.btog.org/cemiplimab-w... #LCSM #LungCancer

“Why it’s an exciting time to be a thoracic surgeon” Hear the discussion in the latest BTOG podcast 👇 https://www.btog.org/btog-nlca-webinar-state-of-the-nation-2026/

Q: How do you know which trial is best for your patient? A: BTOG National Trials Meeting 2026 📍 London 📅 22 July 2026 Register: https://ow.ly/qUaA50YYhaM Sanjay Popat Tom Newsom-Davis Anna Minchom Dr Colin Lindsay Professor Alastair Greystoke Jo Evans.

"Very well organised and good venue, loved the fun run too." Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

BTOG Small Cell Lung Cancer (SCLC) Essential Update Date: Wednesday 14 October 2026 Venue: Cavendish Conference Centre, The Minster Building, London For the multi-disciplinary team

What do you value most about BTOG? Let us know in our 2026 Membership Survey. Your feedback makes a difference. 👉 https://www.btog.org/btog-membership-survey-2026/

Q: How do you know which trial is best for your patient? A: BTOG National Trials Meeting 2026 📍 London 📅 22 July 2026 Register: https://ow.ly/qUaA50YYhaM Sanjay Popat Tom Newsom-Davis Anna Minchom Dr Colin Lindsay Professor Alastair Greystoke Jo Evans.

Lung cancer treatment is more complex than ever—targeted therapies, immunotherapy, multimodality care. But are all patients accessing it equally? Hear the discussion in the latest BTOG podcast 👇 https://www.btog.org/btog-nlca-webinar-state-of-the-nation-2026/

"Multidisciplinary topics were very interesting." Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

What do you value most about BTOG? Let us know in our 2026 Membership Survey. Your feedback makes a difference. 👉 https://www.btog.org/btog-membership-survey-2026/

Earlier diagnosis is rising—and transforming care. The latest BTOG x NLCA podcast explores how screening and stage shift are driving more surgery and better outcomes. Tune in 🎧 https://www.btog.org/btog-nlca-webinar-state-of-the-nation-2026/

BTOG informs members of a new NICE release: amivantamab with carboplatin and pemetrexed recommended for untreated advanced NSCLC with EGFR ex20ins mutations. See NICE for details: https://www.nice.org.uk/guidance/indevelopment/gid-ta11023/documents

"This was an excellent highly academic and research based Congress." Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

BTOG members: this is your chance to influence future events, education and resources. Complete the 2026 survey today. 👉 https://www.btog.org/btog-membership-survey-2026/

NICE recommends osimertinib for EGFR mutation-positive unresectable stage 3 NSCLC after platinum chemoradiotherapy. It must be funded by NHS England within 90 days. Details: https://www.nice.org.uk/guidance/indevelopment/gid-ta11232

The latest BTOG webcast with National Lung Cancer Audit explores 2026 lung cancer data—improvements, challenges, and care impact. Listen now! #lungcancer #lcsm https://www.btog.org/btog-nlca-webinar-state-of-the-nation-2026/

What trials should your patients be on? Join us at the BTOG National Trials Meeting 2026 to explore evolving treatment strategies and UK trial opportunities. 📅 22 July | London Free registration + bursaries available 👉 https://www.btog.org/btog-trials-meeting-2026/

BTOG welcomes the Royal College of Physicians Tobacco Advisory Group's report on smoking, health, and social justice, supporting integrated lung cancer smoking services. https://www.rcplondon.ac.uk/projects/outputs/smoking-health-and-social-justice

#BTOG26 by the numbers: 1,320 attendees (+21% YoY) 314 posters | 41 exhibitors 28% first-time attendees 64K+ impressions & 740 contributors A huge thank you to everyone who made the 24th Annual BTOG Conference such a success 👏 👉 Highlights https://www.btog.org/2026-annual-conference-archive/#BTOG26

"The conference was excellent, well organised, well run, very interesting and relevant. The best part was the trainee development session." https://www.btog.org/2026-annual-conference-archive/

We’re listening. Tell us what’s working—and what could be better—via the BTOG Membership Survey 2026. 👉 https://www.btog.org/btog-membership-survey-2026/

Mark this date! The UK Tobacco and Vapes Bill is an historic step towards a smoke-free generation, protecting future populations from the harms of tobacco addiction. BTOG welcomes this landmark legislation as a critical advance in cancer prevention and public health. https://ow.ly/OxMz50YRP4K

Registrations are now OPEN for the BTOG National Trials Meeting 2026. Know which trials your patient is suitable for. 📍 London | 📅 22 July Free for eligible UK oncology teams + bursaries available. 👉 https://www.btog.org/btog-trials-meeting-2026/

 📢 The NLCA April quarterly data dashboard is now live!✨ This release includes the latest English data up to 30 June 2025. 🔗 Access the dashboard here: rcs-ceu.shinyapps.io/NLCA/  @hqip.bsky.social @btog.bsky.social @lcnuk.bsky.social #LungCancer

We’ve refreshed the BTOG logo! It’s a small but meaningful update that reflects who we are today - a modern, connected community dedicated to improving outcomes for people with thoracic malignancies in the UK.

"Overall really enjoyed it, especially the cardiovascular protection RT, interventional bronchoscopy and academic landscape talks. It was good that speakers were asked to give their main takeaway talks." https://www.btog.org/2026-annual-conference-archive/

Your voice matters. Help shape the future of BTOG by completing our 2026 Membership Survey. It only takes a few minutes. 👉 https://www.btog.org/btog-membership-survey-2026/

BTOG Trials Meeting 2026 Date: Wednesday 22 July 2026 Venue: Cavendish Conference Centre, Duchess Mews, London For oncologists (any level) in routine clinical practice and their research team members (research nurses, research practitioners, etc)

"Great conference. Great venue. Well organised." Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

BTOG Small Cell Lung Cancer (SCLC) Essential Update Date: Wednesday 14 October 2026 Venue: Cavendish Conference Centre, The Minster Building, London For the multi-disciplinary team

"Great experience! Learnt loads as a Foundation Year 1 doctor." Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

📣 The April NLCA Newsletter is here! This month features the recently published State of the Nation report 2026, the upcoming April Data Dashboard, and engagement activities including our latest blog, conference participation and upcoming podcast.  👉 Read here: buff.ly/4uAhrxe @btog.bsky.social

Highlights from our 2026 Annual Conference, watch the video!

"Radiotherapy symposium was excellent, and I am looking forward to watching the videos from the concurrent sessions." Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

Two new BTOG events: BTOG Small Cell Lung Cancer (SCLC) Essential Update Wednesday 14 October 2026 https://www.btog.org/btog-small-cell-lung-cancer-essential-update/ BTOG Trials Meeting 2026 Wednesday 22 July 2026 https://www.btog.org/btog-trials-meeting-2026/

A positive EMA recommendation for tarlatamab marks an important step for relapsed extensive-stage SCLC in Europe. For people facing a disease with limited options after relapse, this matters. Now the focus must also be on fair & timely access. #LCSM www.lungcancereuropenews.eu/news/ema-rec...

We’re excited to announce a major upgrade to the BTOG Annual Conference experience - powered by the latest update to the BTOG event app. These enhancements are part of our ongoing commitment to improving the educational experience and supporting our members in making the most of BTOG events.

Podcast - BTOG Does Lung Neuroendocrine Tumours: Changing the Conversation. What is PRRT? Watch, listen or download the full podcast at Apple Podcasts, Spotify or our website https://btog.org/podcasts

Lung Cancer Advanced Nurse Practitioner, Sandra Wakelin has gained national recognition after becoming @btog.bsky.social Nurse of the Year! 🎉 Sandra received her award in recognition of her outstanding contribution to lung cancer care, including developing nurse-led immunotherapy clinics.

🎙️NLCA Clinical Fellow Lauren Dixon spoke to the Video Journal of Oncology at BTOG 2026, highlighting key findings from the State of the Nation Report 2026. Watch the interview: buff.ly/5yud1f2 @hqip.bsky.social @btog.bsky.social @lcnuk.bsky.social #LungCancer #ClinicalAudit #NHSE

"Fabulous sessions again. Thank you BTOG for your incredible work." Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

Podcast - BTOG Does Lung Neuroendocrine Tumours: Changing the Conversation. Follow-up: 15 years (and why) Watch, listen or download the full podcast at Apple Podcasts, Spotify or our website https://btog.org/podcasts

"Excellent conference. 10/10- will come back next year" Feedback from our Annual Conference 2026. You can read the recap and see photos and short videos on our website https://www.btog.org/2026-annual-conference-archive/

Podcast - BTOG Does Lung Neuroendocrine Tumours: Changing the Conversation. Lung cancer pathway ≠ lung NET pathway: tissue first Watch, listen or download the full podcast at Apple Podcasts, Spotify or our website https://btog.org/podcasts

This time last week, our amazing Annual Conference funrunners were enjoying the sights of Edinburgh before a packed second day of education.